![]() |
市場調查報告書
商品編碼
1954618
毛細管電泳市場規模、佔有率、成長及全球產業分析:依類型、應用和地區劃分的洞察與預測(2026-2034)Capillary Electrophoresis Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025 年全球毛細管電泳 (CE) 市場規模為 4.3875 億美元,預計 2026 年將成長至 4.613 億美元,到 2034 年將達到 6.7337 億美元。這意味著在預測期內,複合年增長率 (CAGR) 為 4.84%。北美地區在 2025 年以 38.05% 的市場佔有率(1.6694 億美元)領先市場,這主要得益於該地區活躍的研發活動和先進的臨床基礎設施。
毛細管電泳是一種分析技術,它利用高壓電場,根據離子和分子的大小和電荷,在毛細管中分離它們。其應用包括核酸分析、蛋白質表徵和臨床診斷。市場成長的驅動因素包括製藥和生技公司研發活動的增加,以及精準醫療的日益普及。
市場動態
驅動因素
癌症和遺傳性疾病等慢性疾病的日益普遍,以及對精準醫療需求的增長,正在推動市場成長。毛細管電泳具有高解析度和高速的分析能力,這對於疾病診斷和個人化醫療至關重要。 2025年1月,美國癌症協會報告稱,美國約有1,860萬人患有癌症,預計到2035年,這一數字將超過2,200萬。患者數量的增加正在推動臨床實驗室採用毛細管電泳技術。
限制因子
高昂的初始投資和營運成本是市場擴張的障礙。先進的毛細管電泳 (CE) 系統的價格從 2 萬美元到 15 萬美元不等,此外還需要支付耗材和維護等營運成本,這限制了小型實驗室和新興市場的採用。
機會
新興市場和學術研究蘊藏著巨大的成長機會。亞太地區、拉丁美洲和非洲各國政府正在加大對製藥和生物技術研發的投入,從而創造了對經濟高效的 CE 系統的需求。桌上型和小型 CE 設備是實驗室入門的理想選擇,有助於這些地區的擴張。學術機構越來越多地將 CE 用於教育和研究,進一步提升了市場的潛力。
挑戰
熟練專業人員的短缺是一項重大挑戰。操作 CE 設備需要具備樣品製備、故障排除和數據分析的技術專長。 2023年2月, "科學與技術研究雜誌" (Journal of Scientific & Technical Research)報道稱,美國約有25,000名醫療技術人員缺口,這限制了先進毛細管電泳系統的有效應用,並減緩了市場增長,尤其是在發展中國家。
市場趨勢
毛細管電泳-質譜聯用(CE-MS)是主要的市場趨勢。 CE-MS能夠增強對生物分子、代謝物和勝肽的定性和定量分析,這些分析對於蛋白質體學、代謝組學和藥物發現至關重要。 2024年6月,CMP Scientific發布了BioSummit CVA系統,這是一款用於高精度蛋白質分析的新一代CE-MS平台,反映了生物製藥研究和臨床診斷領域對CE-MS日益增長的需求。
依產品劃分:市場分為儀器、耗材及軟體。 預計到2026年,耗材細分市場將佔最大佔有率,達到58.53%,這主要得益於學術界、製藥界和生物技術實驗室對毛細管、緩衝液、試劑和試劑盒的持續更換需求。包括自動化和半自動化CE系統在內的儀器預計將以5.0%的複合年增長率成長。
依模式劃分:此細分市場包括毛細管區帶電泳、毛細管凝膠電泳(CGE)及毛細管電層析。 2025年,毛細管電泳(CGE)引領市場,預計2026年將佔43.97%的市佔率。這主要得益於其在核酸和蛋白質分析領域的應用。毛細管電色譜預計將以5.4%的複合年增長率(CAGR)成長。
依應用領域劃分:此細分市場包括核酸分析、藥物研發、蛋白質和勝肽分析以及臨床診斷。核酸分析在2025年佔最大市場佔有率,預計2026年將維持30.4%的市佔率。這主要得益於DNA/RNA定序和基因分型分析的快速發展。蛋白質和勝肽分析預計將以5.8%的複合年增長率(CAGR)增長。
終端使用者包括學術和研究機構、製藥和生物技術公司、臨床實驗室等。學術和研究機構在2025年佔最大佔有率,預計2026年將維持41.36%的佔有率。這要歸功於諸如密西根州立大學2024年Sun Lab CE-MS暑期學校等培訓計畫。製藥和生物技術公司預計將以5.3%的複合年增長率成長。
The global capillary electrophoresis (CE) market was valued at USD 438.75 million in 2025 and is projected to grow to USD 461.3 million in 2026, reaching USD 673.37 million by 2034, reflecting a CAGR of 4.84% during the forecast period. North America dominated the market in 2025 with a 38.05% share, amounting to USD 166.94 million, due to the region's strong research and development (R&D) activities and advanced clinical infrastructure.
Capillary electrophoresis is an analytical technique that separates ions and molecules based on size and charge in a capillary tube using a high-voltage electric field. Its applications include nucleic acid analysis, protein characterization, and clinical diagnostics. The market growth is fueled by increasing R&D initiatives by pharmaceutical and biotechnology companies and rising adoption of precision medicine.
Market Dynamics
Drivers
The increasing prevalence of chronic diseases such as cancer and genetic disorders, combined with the rising demand for precision medicine, is driving market growth. CE offers high-resolution, fast analytical capabilities, critical for disease diagnostics and personalized treatments. In January 2025, the American Cancer Society reported that approximately 18.6 million individuals in the U.S. were living with a history of cancer, a number expected to surpass 22 million by 2035. This rising patient population fuels CE adoption in clinical laboratories.
Restraints
High initial investment and running costs are limiting market expansion. Advanced CE systems range between USD 20,000 and USD 150,000, with additional operational costs for consumables and maintenance, restricting adoption in smaller labs and emerging markets.
Opportunities
Emerging markets and academic research present significant growth opportunities. Governments in Asia Pacific, Latin America, and Africa are investing in pharmaceutical and biotech R&D, creating demand for cost-efficient CE systems. Benchtop and compact CE instruments provide affordable entry points for laboratories, supporting expansion in these regions. Academic institutions are increasingly adopting CE for education and research, further boosting market potential.
Challenges
A shortage of skilled professionals is a key challenge. Operating CE instruments requires technical expertise in sample preparation, troubleshooting, and data analysis. In February 2023, the Journal of Scientific & Technical Research reported a shortage of approximately 25,000 medical technologists in the U.S., restricting effective utilization of advanced CE systems and slowing market growth, especially in developing countries.
Market Trends
Integration with mass spectrometry (CE-MS) is a key market trend. CE-MS enhances qualitative and quantitative analysis of biomolecules, metabolites, and peptides, critical in proteomics, metabolomics, and drug discovery. In June 2024, CMP Scientific launched the BioSummit CVA system, a next-generation CE-MS platform for high-precision protein analysis, reflecting rising adoption in biopharmaceutical research and clinical diagnostics.
By Product: The market is divided into instruments, consumables, and software. The consumables segment dominated in 2026 with a 58.53% share, driven by ongoing replacement needs for capillaries, buffers, reagents, and cartridges in academic, pharmaceutical, and biotechnology labs. Instruments, including automatic and semi-automatic CE systems, are projected to grow at a CAGR of 5.0%.
By Mode: Segments include capillary zone electrophoresis, capillary gel electrophoresis (CGE), and capillary electrochromatography. CGE led the market in 2025, accounting for a 43.97% share in 2026, primarily due to applications in nucleic acid and protein analysis. Capillary electrochromatography is projected to grow at a CAGR of 5.4%.
By Application: Segments include nucleic acid analysis, drug discovery, protein & peptide analysis, and clinical diagnostics. Nucleic acid analysis held the largest share in 2025, with a 30.4% share in 2026, driven by rapid expansion in DNA/RNA sequencing and genotyping. Protein & peptide analysis is expected to grow at 5.8% CAGR.
By End-user: Segments include academic & research institutes, pharmaceutical & biotechnology companies, clinical labs, and others. Academic & research institutes dominated in 2025, with a 41.36% share in 2026, supported by training initiatives such as the 2024 Sun Lab CE-MS summer school at Michigan State University. Pharmaceutical & biotechnology companies are projected to grow at 5.3% CAGR.
Competitive Landscape
The market is led by Thermo Fisher Scientific, Agilent Technologies, Danaher, Helena Laboratories, QIAGEN, Bio-Rad, Bio-Techne, PerkinElmer, Merck KGaA, and Shimadzu Corporation. Key developments include Thermo Fisher's 2025 launch of the SeqStudio Flex Dx Genetic Analyzer, and Agilent's 2024 ProteoAnalyzer system for protein analysis. Companies focus on product innovation and global expansion to strengthen their market presence.
Conclusion
The global capillary electrophoresis market, valued at USD 438.75 million in 2025, is projected to reach USD 461.3 million in 2026 and USD 673.37 million by 2034, at a CAGR of 4.84%. Growth is driven by rising chronic disease prevalence, adoption of precision medicine, expanding academic research, and integration with mass spectrometry. While high costs and skilled labor shortages pose challenges, opportunities in emerging markets and continuous technological advancements are expected to support sustained market expansion through 2034.
Segmentation By Product, Mode, Application, End-user, and Region
By Product * Instruments
By Mode * Capillary Zone Electrophoresis
By Application * Nucleic Acid Analysis
By End-user * Pharmaceutical & Biotechnology Companies
By Geography * North America (By Product, Mode, Application, End-user, and Country)